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Abstract
Background: Viral central nervous system (CNS) infections are common in countries where malaria is endemic but,
due to limited laboratory facilities, few studies have systematically examined the prevalence and clinical consequences
of the presence of viruses in cerebrospinal fluid (CSF) from children with suspected CNS infection.
Methods: We performed a prospective study of Papua New Guinean children hospitalized with signs and symptoms of
CNS infection. CSF samples from 300 children without proven bacterial/fungal meningitis were analyzed for human
herpes viruses (HHV), picornaviruses, influenza, adenoviruses, flaviviruses and bacteria.
Results: Fifty-five children (18%) had viral (42), bacterial (20) or both viral and bacterial (7) nucleic acids (NA) identified
in their CSF. Human herpes viruses accounted for 91% of all viruses found. The identification of viral or bacterial NA was
not associated with any characteristic clinical features. By contrast, malaria was associated with increased identification
of viral and bacterial NA and with impaired consciousness, multiple convulsions and age. Malaria was also inversely
associated with an adverse outcome. Amongst children with HHV infection, those with HHV-6 and −7 were younger,
were more likely have impaired consciousness and had a higher proportion of adverse outcomes than children with
CMV. Dengue and enteroviral infections were infrequent. Adenoviral and influenza infections were not identified.
Conclusion: Infections with HHV-6, HHV-7, dengue and enterovirus have the potential to cause serious CNS disease in
young PNG children. However most HHVs in this malaria-endemic setting should be considered to be the result of
reactivation from a latent reservoir without clinical sequelae.
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Background
The diagnosis and management of central nervous system
(CNS) infections can be challenging in malaria-endemic
tropical countries due to limited laboratory facilities and
therapeutic options. In addition, restricted availability of
health care services that may also be difficult to access can
result in late clinical presentations. Viral pathogens are in-
creasingly identified in patients who present with clinical
features of CNS infection in this setting, where they may
be i) the principal cause of the illness, ii) an alternative
post-mortem diagnosis in patients with an established
clinical diagnosis of cerebral malaria [1], iii) co-incident
pathogens that influence both the CNS manifestations
and subsequent mortality of malaria [2], or iv) as in the
case of neurotropic human herpes viruses (HHVs) that
can establish a latent reservoir through chromosomal inte-
gration of DNA, as a bystander reactivated during an
acute illness [3,4].
The types and proportions of viruses that have been
identified in CNS infections vary by geo-epidemiological
setting. The CNS symptoms caused by cerebral malaria
(CM) are a common indication for lumbar puncture (LP)
and reactivation of HHVs in this situation is well de-
scribed [5]. As a result, geographic variability in the inci-
dence, severity and outcome of CM may impact on the
viruses detected in children presenting with possible CNS
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infections [6]. Other possible factors that might influence
viral CNS infection include local variability in entero-,
adeno- or arbovirus incidence [7], local zoonotic reser-
voirs that may facilitate the emergence of novel viral path-
ogens [8], as well as the choice of virus-specific primers
that are included in diagnostic multiplex PCR tests.
Few studies have systematically assessed inter-
relationships between the presence of viral nucleic
acids (NA) in cerebrospinal fluid (CSF) with specific clin-
ical features and outcome. This is especially important for
HHVs such as varicella zoster (VZV), herpes simplex
viruses-1 (HSV-1), cytomegalovirus (CMV), HHV-6 and
HHV-7 as the presence of NA in the CSF may be result of
reactivation of viral NA that have been integrated into
host cells and may not necessarily represent a primary
acute infection. Such studies are, however, challenging be-
cause of the potentially large number of candidate viruses
and non-viral comparator groups. In a recent study of 513
hospitalized Malawian children, 12 different viruses were
isolated from CSF or post mortem brain biopsies, and the
presence of any virus increased the risk of death especially
in those children with co-incident malaria [2].
Although febrile encephalopathy is common in malaria-
endemic coastal Papua New Guinea (PNG), there have
been few etiologic studies. In a study of children diag-
nosed with likely bacterial CNS infections, no causative
organism was found in most cases [9]. We hypothesized,
therefore, that viruses contribute significantly to the bur-
den of severe CNS illness and its presentation. As part of
a detailed prospective observational study of severe child-
hood infections, we retrospectively analyzed CSF samples
from PNG children hospitalized with signs of a CNS in-
fection but without culture- or latex agglutination-proven
bacterial or cryptococcal infections for the presence of
i) HHVs, ii) picornaviruses, iii) influenza viruses, iv) ade-
noviruses, v) flaviviruses and vi) bacterial pathogens
(Streptococcus pneumoniae (SP), Haemophilus influenzae
type b (Hib) and Neisseria meningitidis).
Methods
Study site
The present study was carried out at Modilon Hospital,
the main referral hospital in Madang Province on the
north coast of mainland PNG, between November 2007
and July 2010. Severe childhood malaria caused by either
Plasmodium falciparum and/or P. vivax is common
[10] and falciparum malaria is known to cause CSF
leukocytosis in approximately 21% of children in this
setting [11]. Hib and SP are leading causes of acute bacter-
ial meningitis [12], and cryptococcal meningoencephalitis
in immunocompetent children occurs occasionally [12].
Hib vaccination was introduced into Madang Province in
2008 and the pneumococcal vaccination was introduced
in 2013. Post-measles complications presenting as sub-
acute sclerosing panencephalitis (SSPE) have also been
relatively common in this area [10]. During the recruit-
ment period of this study, LPs were often performed in
children presenting after a single, uncomplicated febrile
seizure, in accordance with the PNG standard treatment
guidelines at the time [13].
Clinical procedures
All hospitalized children aged between 2 months and
10 years who presented with febrile seizures, impaired
consciousness, coma or other clinical signs and symptoms
suggestive of a possible CNS infection were screened for
inclusion. A standardized case report form that included
demographic and clinical data was completed [14], includ-
ing details of the presenting illness, characteristics of
seizures, vaccination history and past medical history.
Trained research nurses and study clinicians carried out
clinical assessment on admission. Detailed neurological
examinations were performed by study clinicians in pa-
tients presenting with coma or neurological features. A
Blantyre Coma Score (BCS) ≤4 was considered to repre-
sent impaired consciousness [15].
Laboratory procedures
Cerebrospinal fluid was collected under sterile conditions
and examined using standard microbiological procedures
[12]. In brief, an Improved Neubauer Counting Chamber
was used to count CSF leukocytes. All CSF with leukocyte
counts ≥10 cells/μL were plated onto blood and chocolate
agar for bacteriological culture. Cerebrospinal fluid sam-
ples with no cultured pathogen underwent latex agglu-
tination testing (Wellcogen™, Remel Europe Limited,
UK). Protein and glucose were measured using semi-
quantitative dipstick tests. Blood cultures were taken
and placed into an automated blood culture incubator
(Bactec 9050, BD®). Patients with bacteria or fungus
identified from CSF, blood cultures or by latex agglutin-
ation were excluded from further analysis (Figure 1).
Cerebrospinal fluid samples were stored at −80°C for
further viral and bacterial molecular investigations and
subsequently tested in an Australian nationally accre-
dited laboratory. Molecular tests included nested PCR
(nPCR) for HHV-6 HHV-7, picornavirus and adenovirus,
multiplex real-time PCR for varicella zoster [VZV] and
herpes simplex viruses-1 [HSV-1] and −2, tandem multi-
plex real-time PCR for influenza A and B virus, and for
flaviviruses. The presence of CMV, S. pneumoniae, H.
influenzae and N. meningitidis was determined using
real-time PCR. Quantitative PCRs of viral NA, subtyping
of viral species and serological testing was not per-
formed. Malaria in children diagnosed by microscopic
examination of thick blood smears was also subsequently
confirmed by nPCR [10].
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Ethical approval
Written informed consent was obtained from parent(s)/
guardian(s) on admission, and approval for this study
was obtained from the PNG Institute of Medical Re-
search Review Board and the Medical Research Advisory
Committee of the PNG National Department of Health
(MRAC number 10.08).
Data analysis
Two-way comparisons of proportions were by Fisher’s
Exact or Chi-squared tests, and comparisons of medians
were by Mann–Whitney U and Kruskal-Wallis test for
two or more than two groups, respectively. Post-hoc pair-
wise comparisons were performed using Dunn’s test.
Multivariate analysis by logistic regression was performed.
Variables with a univariate P-values <0.10 were included
in a backward stepwise process. The most parsimonious
final model was determined using Aikake’s Information
Criterion. A two-tailed significance level of P < 0.05 was
used throughout.
Results
Of 638 children presenting with clinical features suggest-
ive of CNS infection, a LP was performed in 554 (87%). Of
this latter group, definite diagnoses of bacterial/fungal
meningitis and SSPE were made in 47 (9%) and 22 (4%)
children, respectively. There was insufficient CSF in a fur-
ther 185 children (33%) and 87 of these had a diagnosis of
CM. The remaining 300 (54%) with possible CNS infec-
tions had CSF available for molecular testing (Figure 1).
The median age of this subgroup was 24 (interquartile
range [IQR] 18–29) months and 59% were males. One-
hundred and eighty-three children (61%) had convulsions,
47 (16%) were comatose at the time of admission, and 42
(14%) had impaired consciousness.
Fifty-five of the 300 children (18%) had at least one type
of viral or bacterial NA identified in their CSF, of which
42 had at least one virus identified, including 39 and three
with single- and dual infections, respectively. Overlap be-
tween viral NA, bacterial NA and malaria was common
(Figure 2). Bacterial DNA was identified in 20 children,
with 7 of these also with viral NA present. Children with
bacterial infection included 14, 5 and 1 with SP, HI and
both SP/HI, respectively. Malaria was identified in 93 chil-
dren (31%). An etiologic agent was not identified in 176
children (59%). The characteristics of children by likely
etiologic agent according to malaria status are summa-
rized in Table 1. After adjustment for age, the presence
of viral and bacterial NA was associated with malaria
infection (odds ratio [OR] 2.05 [95% confidence interval
(CI95)] 1.03-4.08, P = 0.04 and 2.62 [1.02-6.8], P = 0.04,
respectively).
Any impairment of consciousness was associated with
the presence of malaria on blood slide (χ2 = 39.6,
P <0.001) and a history of multiple convulsions (χ2 = 9.8,
P = 0.002). The presence of viral or bacterial NA was not
associated with impaired consciousness.
Twenty-eight children (10%) had an adverse outcome,
including 14 (5%) who died. The remaining 14 (5%) were
discharged with neurological disabilities that included
children with motor (n = 6), vision (n = 4), speech (n = 3)
and sensory (n = 1) deficits. In multivariate analysis, an ad-
verse outcome was independently associated with an ab-
normal level of consciousness (OR [CI95] 3.5 [1.4-8.8]),
raised CSF protein (5.4 [1.8-14.9]) and age (1.014 per
Figure 1 Study profile outlining investigations performed on cerebrospinal fluid of Papua New Guinean children with possible central
nervous system infection.
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month [CI95 1.002-1.026]). By contrast, malaria was
associated with a lower chance of adverse outcome
(0.30 [0.09-0.83]). After adjusting for these factors, the
presence of viral or bacterial NA was not associated
with an adverse outcome.
Etiology and clinical patterns of disease in children with
viral infections
i) Human herpes viruses
Human herpes viruses (HHV-6, HHV-7, HSV-1 and
CMV) accounted for 91% of all viruses as single- and co-
Figure 2 Overlap between possible viral, bacterial or malarial infection in Papua New Guinean children with possible central nervous
system infection. The identified viral agent or species are shown in the boxes.
Table 1 Clinical and laboratory characteristics of children in the present study














Age 40 [29–80]a 36 [29–38]b 36 [23–60]c 7 [5–25]a 6.5 [5–18]b 15 [6–44]c <0.001
Male sex 11 (57.9) 5 (50) 37 (53.6) 14 (60.9) 5 (50) 110 (62.5) 0.90
Convulsions 13 (68.4) 7 (70) 50 (72.5) 13 (56.5) 2 (20) 102 (58) 0.03
Neck stiffness 1 (5.3) 2 (20) 13 (18.8) 8 (34.8) 4 (40) 37 (21.0) 0.27
Kernig’s sign positive 0 (0) 0 (0) 4 (5.8) 2 (8.7) 0 (0) 9 (5.1) 0.90
Brudzinski’s sign
positive
0 (0) 0 (0) 1 (1.4) 1 (4.4) 0 (0) 3 (1.7) 0.96
Impaired consciousness 10 (52.6) 4 (40) 38 (55.1)c 5 (21.7) 1 (10) 32 (18.2)c <0.001
Haemoglobin (g/L) 71 [58–106] 78.5 [71–106] 85 [68–102] 91 [65–111] 101.5 [89–106] 96 [84.5–109] 0.07
White blood cells
(X109/L)
8.4 [5.7–14.2] 7.4 [5.6–10] 8.6 [5.7–11.7] 7.9 [5.3–15.5] 8.6 [4.8–13.2] 9.8 [7.4–12.7] 0.50
Platelets (X109/L) 100 [63–222]d 147 [100–238] 103 [46–206]c 368 [197–378] 618 [305–992] 265 [165–390]c,d <0.001
Lactate (mmol/L) 2.7 [2.0–4.6] 1.8 [1.2–2.4] 3.4 [2.0–5.3] 1.2 [1.0–4.2] 4.3 [3.3–15.7] 2.4 [1.9–3.3] 0.01
CSF leukocytes
(cells/μL)
0 [0–5] 2.5 [0–30] 0 [0–5] 5 [0–10] 0 [0–5] 0 [0–5] 0.04
CSF protein (g/L) 0.3 [0.3–0.3] 0.3 [0.15–0.3] 0.3 [0.15–0.3] 0.3 [0.3–0.3] 0.3 [0.3–0.3] 0.3 [0.15–0.3] 0.35
Death 1 (5.3) 0 (0) 2 (2.9) 1 (4.4) 1 (10) 9 (5.1) 0.93
Discharged with
disability
2 (10.5) 0 (0) 1 (1.4) 2 (8.7) 0 (0) 9 (5.1) 0.46
Data are numbers (percent) for dichotomous variables or medians (interquartile range) for continuous variables. Due to viral and bacterial co-infections in 7
children, numbers do not add to 300.
aSignificant post-test pairwise comparison (P < 0.05) between malarial and non-malarial infection in children with viruses identified.
bSignificant post-test pairwise comparison (P < 0.05) between malarial and non-malarial infection in children with bacteria identified.
cSignificant post-test pairwise comparison (P < 0.05) between malarial and non-malarial infection in children without virus or bacterial nucleic acids identified.
dSignificant post-test pairwise comparison (P < 0.05) between malarial-viral co-infection and no pathogen identified.
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infections. Evidence of HHV-6 and HHV-7 infection in
CSF was found in 21 (7%) of all children (Table 2). When
compared to CMV, children with HHV-6 and −7 were
more likely to have impaired consciousness (11 vs 3, P =
0.04), with trends towards higher proportions of complex
seizures and adverse outcomes (Table 2). Four children
with HHV-6 or −7 viruses had adverse outcomes, includ-
ing one child with HHV-7 infection who died.
The fatal HHV-7 case was a child aged 9 years admitted
with multiple generalized convulsions. He was deeply co-
matose and had signs of meningism. He had a CSF
lymphocyte count of 5 cells/μL, an elevated CSF protein
of 3.0 g/L, and reduced CSF glucose (<5.5 mmol/L). Mal-
aria microscopy as well as blood and CSF cultures were
negative, and hemoglobin (111 g/L), total white blood cell
density (15 × 109/L), platelet density (368 × 109/L), blood
glucose (7.0 mmol/L) and blood lactate (1.0 mmol/L) were
normal or within acceptable limits. Despite supportive
therapy, his condition progressively deteriorated and he
died after 3 days. Promptly-obtained post-mortem brain
tissue showed extensive necrosis with neutrophilic infiltra-
tion, and there were reactive endothelial cells within cere-
bral vessels. Special histopathological stains for bacteria,
fungi and Mycobacterium were negative. Cerebrospinal
fluid PCR was subsequently positive for HHV-7 but nega-
tive for SP, Hib, N. meningitidis, picornaviruses, influenza
viruses and flaviviruses. Nested PCR of brain tissue for
malaria was also negative.
Seventeen children had evidence of CMV identified
from CSF, 13 as single infections and four as mixed infec-
tions. Eleven (64%) of the children with CMV infection
also had confirmed malaria at the time of admission. Only
one child with CMV infection was discharged with cogni-
tive impairment and none died.
Three children had evidence of HSV-1 infection, of
which two had multiple co-infections (Figure 1). One
child presenting with a focal, prolonged seizure lasting
more than 15 minutes had HSV-1/HHV-7/SP identified in
CSF as well P. falciparum in peripheral blood. Cerebro-
spinal fluid analysis revealed predominantly polymorphic
white cells but there was no growth on bacterial culture.
Another child had HSV-1/HHV-6/SP co-infection and
presented with lower respiratory tract infection (LRTI)
without convulsions and had a normal level of con-
sciousness. The third child with HSV-1 mono-infection
presented following a simple febrile convulsion. All three
children were treated with intramuscular artemether
and chloramphenicol and survived without neurological
sequelae.
ii) Enterovirus
The only picornavirus identified in this study was an en-
terovirus identified from the CSF of an 8-month old infant
who presented with respiratory symptoms and a single
seizure lasting approximately 10 minutes. On admission,
she was irritable. Lumbar puncture revealed normal CSF
findings and she was discharged well. The enterovirus
could not be further identified due to an insufficient vol-
ume of CSF.
iii) Flavivirus
Three children that had dengue type-2 infection presented
to hospital within 9 days of each other. Two of these
children were admitted on the same day with febrile
convulsions and both were treated empirically with
intramuscular artemether and chloramphenicol. One
child had SP/dengue co-infection by nPCR (Figure 1)
and another had P. falciparum/dengue co-infection.
Both were discharged well without disability. The third
child presented in deep coma and with clinical signs of
meningeal irritation. He had a CSF cell count of 30
cells/μL (predominantly lymphocytes), but CSF and
blood cultures were negative. He was also hypoglycemic
(blood glucose 1.6 mmol/L), acidotic (blood lactate
15.1 mmol/L) and moderately thrombocytopenic (plate-
lets 70 × 109/L). He was diagnosed with viral encephal-
itis, and despite supportive therapy, he died within an
hour of admission. His guardians declined a post mor-
tem examination but CSF nPCR and plasma NS1 anti-
gen tests were positive for dengue virus.
Table 2 Clinical and laboratory features in patients with HHV-6 and −7 compared to those with CMV
HHV6, 7 (n = 21*) CMV (n = 17*) P-value¶
Age (months) 24 (8–56) 29 (6–38) 0.698
Impaired consciousness 11 (24) 3 (12) 0.04
Complex seizure 4 (19) 0 (0) 0.113
Cerebrospinal fluid ≥5 (cells/μL) 11 (52) 9 (53) 0.615
Protein (≥1 g/L) 4 (19) 1 (6) 0.243
Adverse outcome Permanent disability 3 (14) 1 (6) 0.355
Mortality 1 (5) 0 (0)
Data are numbers (percent) for dichotomous variables or medians (interquartile range) for continuous variables.
*The child with HHV-7/CMV coinfection is included in both groups; ¶Fisher’s exact test or Mann Whitney U test used.
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iv) Adenovirus
Adenovirus was not identified in any child with febrile
encephalopathy.
Discussion
The present study provides the first comprehensive data
relating to the etiology of possible CNS infections in
hospitalized children from a malaria-endemic area of
PNG. Of 300 children without SSPE or proven bacterial/
fungal meningitis, a possible candidate bacterial, viral or
parasitic agent, or combination of agents, was identified
in only 41%. There were few characteristics that differed
between the six diagnostic groups, and thus no reliable
clinical differentiation between the effects of bacteria or
viruses in the CSF. Many children had more than one
possible infection with overlap across different diagnos-
tic groups.
Malaria appeared to have the most important effect on
clinical characteristics of children with possible CNS in-
fections. In multivariate analyses, the presence of malaria
on blood slide was associated with the detection of bacter-
ial or viral NA. Malaria was also independently associated
with impaired consciousness and multiple convulsions,
but after adjustment for other factors was inversely associ-
ated with an adverse outcome. Neither the presence of
viral or bacterial DNA was independently associated with
an adverse outcome or impaired consciousness. In post-
hoc pairwise comparisons, children with malaria were
older than their counterparts without malaria, regardless
of the presence of viral or bacterial NA in the CSF.
Human herpes viruses accounted for the majority of
the viral infections but there were some clinical differ-
ences within this group of related viruses. Children with
HHV-6 or HHV-7 were much younger and more likely
to have impaired consciousness than those with CMV
infections, with an associated trend to a higher rate of
complex seizures and adverse outcomes. These observa-
tions are consistent with the notion that acute infections
associated with HHV6 and −7 might be more likely to
present in very young children. The death of the child in
whom HHV-7 was the only identifiable etiologic agent
highlights the possibility that very severe disease and
death may occasionally result from infections with these
viruses.
Although HHV-6 and −7 have been shown to cause
encephalitis and are associated with febrile convulsions
in very young children [16-20], demonstrating a causal
relationship between the presence of viral NA and clin-
ical disease can be difficult. Like most HHVs, HHV-6
and −7 also are considered neurotropic [19-21] with the
capacity to establish a latent reservoir. Re-activation of
latent infections can cause clinical disease in immune-
suppressed individuals [3,22,23], but data from develop-
ing countries suggest that malaria infection may also
predispose to re-activation of HHVs. A small study of 49
Kenyan children with cerebral malaria found that HSV-1
was present in CSF from four children [5]. In a study
from Uganda, there was an increase in Epstein-Barr
virus in plasma and saliva from children with uncompli-
cated malaria which cleared with antimalarial treatment
[3], suggesting that acute P. falciparum infection may
cause HHV reactivation. Our data also support the hy-
pothesis that malaria might cause re-activation of HHVs
in some children but without major clinical conse-
quences. Malaria was associated with a 2-fold increase in
the chance of detecting a virus when compared to chil-
dren without malaria. However, although HHVs made
up >90% of possible viral pathogens isolated, they did
not appear to have a characteristic clinical phenotype.
A recent Malawian study found that malaria-virus co-
infections that included infections due to rabies, entero-
viruses, mumps and adenoviruses were associated with
an increased risk of seizures compared to either infec-
tion alone. Mortality in this group was also significantly
higher than in children with malaria infection alone [2].
The apparent inconsistency between this finding and the
results of the present study may reflect differences in the
geographic distribution of encephalopathic viruses as
well as their relative propensity to establish a latent reser-
voir. In addition, regional differences in malaria preva-
lence, incidence of severe malaria and associated mortality
[5], temporal variability in enterovirus, adenovirus and/or
arbovirus incidence [7], local zoonotic reservoirs contrib-
uting to the emergence of novel pathogens [8], and the
choice of virus-specific primers that are included in the
multiplex PCR tests employed during each study may all
contribute to the distinctive local epidemiology of CNS
infections.
Our data also confirm that viral pathogens including
dengue and enterovirus that are commonly associated
with clinically significant CNS infections occur, albeit
rarely, in PNG children from the Madang area. Despite
the low incidence of dengue in hospitalized children in
the present study (1%), the child with dengue type-2 en-
cephalitis died. This is the first reported case of death
due to dengue encephalitis in PNG, highlighting that
dengue should be considered an etiologic agent in PNG
patients with undiagnosed CNS infections. Interestingly,
the clustering of admissions of the three children with
dengue type-2 infections indicates that transmission may
be seasonal. Only one case of enterovirus infection was
documented in our study, but was unable to be typed
further.
In contrast to reports from developed [24,25] and other
tropical [2,26,27] countries, influenza, adenoviruses and
other HHVs were not significant contributors to the bur-
den of encephalopathy in our hospitalized children [7,28].
Epstein-Barr virus, commonly associated with Burkitt’s
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lymphoma in malaria-endemic areas including PNG
[29,30], was not identified in the present study and neither
was HHV-8, perhaps because PCR was performed on CSF
rather than blood or saliva [3,31].
The present study also raises the possibility of occult
culture-negative bacterial infections in children with fea-
tures of CNS infection. Bacterial infections not identified
by blood or CSF culture, or by bacterial antigen testing,
were identified in 6.7% of children using molecular diag-
nostic methods. Although one child with SP/Hib co-
infection died, our data do not reveal any clear clinical
pattern associated with occult bacterial infections. As
with viral infections, the presence of malaria increased
the chance of detecting a bacterial pathogen by approxi-
mately 2-fold. Although the clinical relevance of ‘inci-
dental’ bacterial infections is not clear from our data,
severely ill children with negative CSF or blood cultures
might still benefit from empirical use of antibiotics.
Despite detailed investigations covering a large number
of candidate etiologic agents, a large proportion of our
children with possible CNS infection did not have a con-
vincing final diagnosis. This warrants further studies in
this group of vulnerable children, especially as increasingly
sensitive molecular and other diagnostic tools continue to
be developed [32]. In addition, non-infective causes of en-
cephalopathy, such as environmental toxins, could also be
considered where no pathogens are detected.
Our data have some limitations, particularly with the
challenges of delineating between acute infections and
reactivation of HHVs. Firstly, sophisticated molecular
analyses differentiating HHV-6 DNA from actively repli-
cating virus or forms associated with chromosomal inte-
grated DNA were not performed [4]. Secondly, we did
not perform tests to define whether children with HHV-
6 had HHV-6A or 6B. Thirdly, we did not have neuro-
imaging diagnostics in our setting that could assist in
the diagnosis and management of brain infections. Fi-
nally, we did not have plasma available for serological
tests such as species-specific immunoglobulin M or G
that might assist with making a diagnosis of an acute or
latent infection, respectively.
Conclusion
The present study indicates that viral infections such as
dengue, enterovirus and perhaps HHV-6 and −7 can
cause serious CNS disease in some PNG children. How-
ever, there is no apparent effect of the presence of viral
NA on clinical features and outcome in this group. By
contrast, malaria has a strong positive effect on the like-
lihood of detection of viral and bacterial NA, is itself as-
sociated with clinically important characteristics such as
impaired consciousness, and is an independent predictor
of a good outcome. This suggests that HHVs may be the
result of reactivation from a latent reservoir as a result
of malaria without clinical sequelae in most cases. Al-
though the capacity to diagnose significant viral infections
in PNG is limited, these data should inform clinicians as
to differential diagnoses in an encephalopathic child that
should now include dengue and enterovirus infections.
Antiviral medications such as aciclovir are routinely not
available in PNG. Although antiviral medications have
been used successfully in a small number of immunocom-
petent patients with encephalomyelitis due to HHV-6
[33], the lack of data from well-designed studies, high
medication costs and the lack of capacity to make a diag-
nosis, preclude the incorporation of antiviral recommen-
dations into standard treatment guidelines for countries
like PNG. The present data do not argue for a change to
these guidelines.
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